| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | Chief Financial Officer | Common Stock | 91,996 | $2,101,188 | $22.84 | 02 Jan 2026 | Direct |
| Vir Biotechnology, Inc. | CFO | Common Stock | 230,712 | $352,989 | $1.53 | 23 Feb 2023 | Direct |
| Vir Biotechnology, Inc. | CFO | Stock Option (Right to Buy) | 50,000 | $76,500 | $1.53 | 22 Feb 2022 | Direct |
| Ultragenyx Pharmaceutical Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 28,160 | 01 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | 02 Jan 2026 | 1 | -$71,946 | 4 | Chief Financial Officer | 05 Jan 2026, 16:07 |
| RARE | Ultragenyx Pharmaceutical Inc. | 10 Dec 2025 | 1 | -$112,087 | 4 | Chief Financial Officer | 11 Dec 2025, 12:10 |
| RARE | Ultragenyx Pharmaceutical Inc. | 13 Oct 2025 | 1 | -$250,252 | 4 | Chief Financial Officer | 14 Oct 2025, 12:15 |
| RARE | Ultragenyx Pharmaceutical Inc. | 06 Mar 2025 | 1 | -$72,114 | 4 | Chief Financial Officer | 10 Mar 2025, 12:53 |
| RARE | Ultragenyx Pharmaceutical Inc. | 01 Mar 2025 | 2 | $0 | 4 | Chief Financial Officer | 04 Mar 2025, 19:56 |
| RARE | Ultragenyx Pharmaceutical Inc. | 10 Oct 2024 | 1 | -$393,853 | 4 | Chief Financial Officer | 11 Oct 2024, 16:48 |
| RARE | Ultragenyx Pharmaceutical Inc. | 01 Mar 2024 | 2 | $0 | 4 | Chief Financial Officer | 05 Mar 2024, 20:23 |
| RARE | Ultragenyx Pharmaceutical Inc. | 09 Oct 2023 | 2 | $0 | 4 | Chief Financial Officer | 10 Oct 2023, 12:50 |
| RARE | Ultragenyx Pharmaceutical Inc. | 09 Oct 2023 | 0 | $0 | 3 | Chief Financial Officer | 10 Oct 2023, 12:48 |
| VIR | Vir Biotechnology, Inc. | 23 Feb 2023 | 1 | -$58,387 | 4 | CFO | 24 Feb 2023, 19:36 |
| VIR | Vir Biotechnology, Inc. | 17 Feb 2023 | 1 | -$61,298 | 4 | CFO | 21 Feb 2023, 18:22 |
| VIR | Vir Biotechnology, Inc. | 22 Feb 2022 | 2 | $0 | 4 | CFO | 24 Feb 2022, 20:29 |
| VIR | Vir Biotechnology, Inc. | 17 Feb 2022 | 1 | -$76,411 | 4 | CFO | 22 Feb 2022, 16:00 |